|

quaratusugene ozeplasmid Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: REQORSA, Reqorsa

Pipeline

Phase 1/2: 2

Top Sponsors

  • Genprex, Inc.2

Indications

  • Lung Cancer2
  • Cancer2
  • Small Cell Lung Cancer Extensive Stage1
  • Carcinoma, Non-Small-Cell Lung1

Los Angeles, California1 trial

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

Valkyrie Clinical Trials

Phase 1/2

Lone Tree, Colorado1 trial

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Rocky Mountain Cancer Centers, LLP

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.